Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec and Gemzar in Recurrent Ovarian Cancer
NCT00928642Phase 2Completed
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Start
- Jun 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in ovarian cancer, primary peritoneal cancer (PPC), sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine. Started Jun 2009; status: completed.
02
Drugs
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00928642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928642.